ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate → 8-[2-(2-Azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane

HRID 928580
印刷

反応式

HRID 928580 の反応式
[CH:1]12[N:8]([C:9]3[C:10]4[C:32]([C:33]5[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=5)=[CH:31][S:30][C:11]=4[N:12]=[C:13]([O:15][CH:16]4[CH2:21][CH:20]5[CH2:22][CH:17]4[CH2:18][N:19]5C(OC(C)(C)C)=O)[N:14]=3)[CH:5]([CH2:6][CH2:7]1)[CH2:4][O:3][CH2:2]2>C(Cl)Cl.FC(F)(F)C(O)=O>[CH:20]12[CH2:22][CH:17]([CH:16]([O:15][C:13]3[N:14]=[C:9]([N:8]4[CH:1]5[CH2:7][CH2:6][CH:5]4[CH2:4][O:3][CH2:2]5)[C:10]4[C:32]([C:33]5[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=5)=[CH:31][S:30][C:11]=4[N:12]=3)[CH2:21]1)[CH2:18][NH:19]2
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 1

HCID 89579513Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate

生成物 1

HCID 895799438-[2-(2-Azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane収率 2.7%

試薬・触媒・溶媒 2

HCID 6344Dichloromethane溶媒HCID 6422Trifluoroacetic acid溶媒

実験手順

Tert-butyl 5-[4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-5-phenyl-thieno[2,3-d]pyrimidin-2-yl]oxy-2-azabicyclo[2.2.1]heptane-2-carboxylate (269 mg, 0.503 mmol) was dissolved in DCM (2 mL) and trifluoroacetic acid (2 mL). The mixture was stirred at room temperature for 2 hrs and then evaporated. The residue was dissolved in water (2 mL) and DCM (2 mL). Solid sodium bicarbonate was added to neutralize the remaining acid. The layers were separated and the aqueous was extracted with DCM (2×2 mL). The combined organic layers were evaporated to give a brown solid. This was purified by preparative HPLC (acidic method 1). Fractions containing the target compound (by LCMS) were combined and evaporated. The residue was dissolved in methanol and applied to an SCX cartridge (2 g, equilibrated with methanol). The cartridge was washed with methanol (2 column volumes) then 0.5 M ammonia in methanol (2 column volumes). The ammonia solution was evaporated to give 8-[2-(2-azabicyclo[2.2.1]heptan-5-yloxy)-5-phenyl-thieno[2,3-d]pyrimidin-4-yl]-3-oxa-8-azabicyclo[3.2.1]octane as a white solid (6 mg). LCMS RT=3.16 min. M+1=435.

後処理

  1. customevaporated
  2. dissolutionThe residue was dissolved in water (2 mL)
  3. additionSolid sodium bicarbonate was added
  4. customThe layers were separated
  5. extractionthe aqueous was extracted with DCM (2×2 mL)
  6. customThe combined organic layers were evaporated
  7. customto give a brown solid
  8. customThis was purified by preparative HPLC (acidic method 1)
  9. additionFractions containing the target compound (by LCMS)
  10. customevaporated
  11. dissolutionThe residue was dissolved in methanol
  12. washThe cartridge was washed with methanol (2 column volumes)
  13. customThe ammonia solution was evaporated

出典と根拠

ORDレコード
ord-074e5b7f4d51400fb0cccd52cd3efb82
出典データセット
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09290511B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート